Jim Cramer says Finish Line posted a winning quarter and Alder Biopharma will determine the face of biotech.» Read More
Robert DeMartini, New Balance president and CEO, explains how a change in U.S. trade policy could force him to shutdown factories and lay off workers.
Skechers will pay $40 million to settle charges in an advertising case, reports CNBC's Darren Rovell.
Mad Money host Jim Cramer explains why Nike's so-called disappointing quarter was actually quite good, and reminds investors that future orders are the key metric when deciding whether or not to buy the stock.
With a 47 percent year-to-date increase in its share price, apparel giant VF is the No. 9 stock in the S&P top performers of 2011. But should you buy, sell or hold?
Mad Money's Jim Cramer reviews a checklist investors should analyze before buying a stock, using Nike as an example.
With major sporting events next year and acquisition of a franchise license ahead, Nike appeared poised for a strong 2012, “Fast Money” pros said Tuesday.
The Fast Money traders with the play on Nike's positive earnings, and Robert Samuels, WJB Capital, makes a case for the footwear maker, saying the company has a cash rich balance sheet and is taking shares from smaller competition.
Is Foot Locker or Lululemon a better play for investors? Christopher Svezia, Susquehanna Financial Group, and Stacey Widlitz, SW Retail Advisors share their picks.